C03V

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameC03V
Drug Alias NameC-03-V
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 15
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsAsthmaInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTeva Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsAsthmaInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A